Literature DB >> 32265174

Stemmed acetabular cup as a salvage implant for revision total hip arthroplasty with Paprosky type IIIA and IIIB acetabular bone loss.

Samir-Pierre Issa1, David Biau2, Philippe Leclerc2, Antoine Babinet2, Moussa Hamadouche2, Philippe Anract2.   

Abstract

INTRODUCTION: Certain cases of repeated acetabular loosening with severe bone loss are hardly amenable to reconstruction using a Kerboull-type plate with allograft. This limitation is more likely when the severe bone loss occurs in older adults with significant comorbidities that may require a faster procedure. In these indications, a stemmed acetabular cup may be an alternative, although the outcomes have not been well defined, especially for a version where the peg is coated with porous material and additional screws can be added. This led us to conduct a retrospective study to determine: (1) whether a stemmed cup anchored in the iliac isthmus is a viable alternative in these situations, (2) the complication rate and (3) the revision rate for any reason. HYPOTHESIS: A stemmed cup anchored in the iliac isthmus is a viable alternative in cases of repeated revision with severe acetabular bone loss.
MATERIALS AND METHODS: We performed a retrospective single-center study. Sixteen Integra™ cups were implanted in 14 patients (mean age 72.8±10.4 years, minimum-maximum: 58-95) who had aseptic acetabular loosening combined with severe acetabular bone loss graded as Paprosky IIIA in 7 hips and IIIB in 9 hips. The patients had undergone a mean of 2.7±1.8 (minimum-maximum: 1-6) procedures (i.e. primary and/or revision arthroplasty) before this cup was implanted. The cup's survivorship at the time of review and the complication rate were determined.
RESULTS: At a mean follow-up of 48.8±23.4 months (minimum-maximum: 7-85), two patients had died and two were lost to follow-up. Six hips experienced one or more complications (37.5%): three infections (18.8%), two mechanical failures (12.5%) and one dislocation (6.7%). The cup had to be removed in three patients (18.8%). These complications required reoperation, thus the cumulative incidence of revision for any reason at 5 years was 31% (95% CI: 11-55%).
CONCLUSION: Despite the high complication and revision rates, we believe the stemmed acetabular cup is a viable alternative in salvage reconstruction procedures. LEVEL OF EVIDENCE: IV, Retrospective case study.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acetabular loosening; Complications; Ice cream cone prosthesis; Multiple revisions; Severe acetabular bone loss; Stemmed acetabular cup; Survival

Mesh:

Year:  2020        PMID: 32265174     DOI: 10.1016/j.otsr.2020.01.012

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  4 in total

Review 1.  The iliac stemmed cup in reconstruction of the acetabular defects secondary to tumor resection: a systematic review of literature.

Authors:  Carmine Zoccali; Giuseppe Giannicola; Giovanni Zoccali; Elisa Checcucci; Alessandra Scotto di Uccio; Dario Attala; Ciro Villani
Journal:  Arch Orthop Trauma Surg       Date:  2022-10-01       Impact factor: 2.928

2.  Augmenting Pathologic Acetabular Bone Loss With Photodynamic Nails to Support Primary Total Hip Arthroplasty.

Authors:  Marilyn Heng; Mitchell S Fourman; Aiden Mitrevski; Emily Berner; Santiago A Lozano-Calderon
Journal:  Arthroplast Today       Date:  2022-10-11

Review 3.  Acetabular Peri-Prosthetic Fractures-A Narrative Review.

Authors:  Gautier Beckers; Az-Eddine Djebara; Morgan Gauthier; Anne Lubbeke; Axel Gamulin; Matthieu Zingg; Johannes Dominik Bastian; Didier Hannouche
Journal:  Medicina (Kaunas)       Date:  2022-05-01       Impact factor: 2.948

4.  A novel and secure technique of stemmed acetabular cup implantation in complex hip reconstructions: a comparative study and technical note.

Authors:  Julien Mallet; Mike Persigant; Yonis Quinette; Kevin Brulefert; Denis Waast; Gualter Vaz; Christophe Nich; François Gouin; Vincent Crenn
Journal:  Int Orthop       Date:  2021-09-28       Impact factor: 3.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.